This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.
Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. In the recent case Hemp Industries Associations v.
CannaTech showcases the biggest industry thought leaders, known for their significant and groundbreaking contributions to the global cannabis market in fields such as science, finance, government policy and tech. Mr. Feldmann’s talk is titled, “The United States Federal Government and the Cannabis Industry.
FEDERAL TAXATION OF CANNABIS: A PRIMER. The manufacture, distribution, and possession of cannabis is illegal under federal law, which categorizes it as a Schedule 1 controlled substance. states have therefore, in one form or another, defied federal law with respect to cannabis use and distribution in their respective jurisdictions.
On July 14, 2021, Senators Chuck Schumer (D-NY), Ron Wyden (D-OR), and Cory Booker (D-NJ) released the discussion draft of historic federal cannabis legalization legislation, the Cannabis Administration and Opportunity Act (CAOA). We strongly encourage participation in this important opportunity to shape federal cannabispolicy.
The DEA couldn’t figure out at first why a bunch of rednecks in Cottondale, Florida, had 24-carat gold Rolex watches and were driving Mercedes S500’s, Cobb told Fox News in a recent interview. And that is how he got his start in cannabis. That cannabis came right from Pablo Escobar’s Medellín.”.
Starting today, US manufacturers and merchants can apply through LegitScript to certify CBD products and websites that are in compliance with USDA, FDA, FTC, and DEA regulations, as well as state-specific laws.
The American Bar Association (ABA) adopted a resolution on Monday that calls on Congress to allow states to set their own marijuana policies and recommends rescheduling or descheduling cannabis under federal law.
percent delta-9 tetrahydrocannabinol or opportunities for remediation or alternative uses; the feasibility of producer compliance with sampling timetables; the feasibility of producer compliance with reporting requirements; and. 2020 is likely going to be another big year for cannabis, especially at the federal level.
PUBLISHER: CANNABIS LAW REPORT. There are remaining concerns as to the state health department’s treatment policy towards these products as well. Darren has worked on several legal issues in the cannabis space, specializing thus far in industrial hemp, regulatory compliance (hemp and marijuana), and civil and commercial litigation.
A new state regime for legal cannabis brings with it a new group of investigators and enforcers. Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). The Legal Gray Area of the Initial Grow. How do you do that?
A new state regime for legal cannabis brings with it a new group of investigators and enforcers. Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). The Legal Gray Area of the Initial Grow. How do you do that?
A new state regime for legal cannabis brings with it a new group of investigators and enforcers. Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). The Legal Gray Area of the Initial Grow. How do you do that?
A new state regime for legal cannabis brings with it a new group of investigators and enforcers. Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). The Legal Gray Area of the Initial Grow. How do you do that?
The first argument was that according to the DEA, Delta-8 remains a schedule I substance because its method of manufacture is “synthetically-derived.” Put simply, regardless of its method of manufacture, if Delta-8 THC is derived from the Cannabis sativa L. plant, it is not synthetic. FOR MORE INFORMATION. 202.263.4128. 202.263.4145.
Many states are now scrambling to close legal loopholes in their drug laws to bring delta-8 into regulatory compliance. In Oregon, lawmakers are working on regulations that would create a definition for “artificially derived” cannabinoids, in order to regulates such compounds under the state’s medical and adult-use cannabis laws.
Despite progress over the past decade, the cannabis industry still struggles to access a fundamental piece of the U.S. Congress should either legalize cannabis or stop deputizing banks as drug enforcement investigators. To be clear, the existing policy does not ban financial services for the cannabis industry.
CPA’s “ PUBLISHER: CANNABIS LAW REPORT. – It is fascinating to step back and observe how the mindset of many in the cannabis industry seems to work. 280E is effectively repealed and cannabis businesses are no longer subject to the broad disallowance of expenses. Federal Legalization – Then What?
Achieved 23% revenue growth in Q1 2022 versus Q1 2021 driven by strong double-digit growth in both cannabis and other consumer products businesses. Maintained #1 market share 1 in tracked Canadian recreational cannabis market amid a highly competitive landscape. presence through broad portfolio of innovative CBD and CPG brands.
A new state regime for legal cannabis brings with it a new group of investigators and enforcers. Depending on the allegations, companies must also stay attentive to federal criminal exposure if information is shared with the Drug Enforcement Agency (DEA). The Legal Gray Area of the Initial Grow. How do you do that?
PUBLISHER: CANNABIS LAW REPORT. On February 14 th the Los Angeles Times published an article by Joe Mozingo entitled “Cannabis Farm Was a Model for California’s Legal Industry”. Every individual involved in plant touching activities in California’s cannabis industry is a criminal. AUTHOR: aBIZinaBOX Inc. CPAs – Jordan S.
In The Weeds welcomes the new year, as well as a number of new cannabis laws and policies taking effect around the country in 2022. 1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. Maine Appeals Out-of-State Cannabis Dispensary Ruling. McGuireWoods LLP. Happy 2022!
PUBLISHER: CANNABIS LAW REPORT. The website Weedmaps bills itself as “a community where businesses and consumers can search and discover cannabis products, become educated on all things cannabis, review cannabis businesses and connect with other like-minded users,” but is more succinctly described as Yelp for pot.
Questions for the Local Regulators panel, moderated by Isa Perez, were sourced from a survey we sent to licensed California operators, as well as Meadow partners, community members, and Meadlowands attendees, representing concerns from across the California cannabis industry and community. Photo Credit: Kandid Kush.
of the global population uses cannabis annually, making it the most commonly used drug worldwide. During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. It should be noted that cannabis and marijuana are not interchangeable terms.
After attending the International Cannabis Business Conference (ICBC) in Berlin at the end of April, I was reminded, yet again, of how draconian U.S. Much of it was driven by Germanys newly formed government keeping its quasi-legalization policy intact, even if adult-use trials remain uncertain. marijuana laws truly are.
Achieves 37% revenue growth in FY 2021 with strong double-digit growth across both cannabis and other consumer products businesses. Net revenue increased 37% during FY 2021 over the prior year driven by double-digit growth across Canadian cannabis, international cannabis and other consumer products businesses.
PUBLISHER: CANNABIS LAW REPORT. . Nationally, on October 17, 2018, Forbes observed, “ Congress is out of step with the American people and the states on cannabis, ” Rep. There’s no question: cannabis prohibition will end. People are excited about cannabis as medication, but they don’t know anything about it.
The Drug Enforcement Administration (DEA) issued an interim final rule on hemp (“DEA hemp rule” or “rule”) on August 20, 2020. As many of our readers will know, the 2018 Farm Bill defines hemp as cannabis with a THC concentration of not more than 0.3 Challenging the DEA hemp rule.
The Drug Enforcement Administration (DEA) issued an interim final rule on hemp (“DEA hemp rule” or “rule”) on August 20, 2020. As many of our readers will know, the 2018 Farm Bill defines hemp as cannabis with a THC concentration of not more than 0.3 Challenging the DEA hemp rule.
I feel like we’re living in an upside down world when it comes to cannabis legalization at the federal level. The main reason being that Dems, despite in being in full control of Congress and the White House, just can’t get the ball across the line on a number of cannabis reform bills. Why is Rep.
8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. In addition to the arduous FDA approval process, potential psychedelic therapies would also require complying with requirements from the Drug Enforcement Administration (DEA).
MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. What is the legal difference between cannabis and low-THC cannabis? Regular cannabis does not have to meet the same requirements.
Speakers will describe how the DEA has handled these granted exemptions, such as filing a permit to import sacrament from another country and bringing back sacrament and going through customs. The panel will also address the DEA’s guidelines for applying for an exemption, and the potential costs, risks, and rewards of going ‘above ground’.
Delta-8 THC is making big waves in the cannabis industry at the minute, but with warnings from the FDA and CDC , not to mention harrowing accounts from users , it’s clear there’s more going on with the novel cannabinoid than meets the eye. And that was just the beginning. But it can’t really be as bad as it sounds, can it?
The commercialization of cannabis is here but federal legalization has not yet come to our shores. As of this writing, cannabis remains a prohibited Schedule 1 drug, defined by the DEA as having “no currently accepted medical use and a high potential for abuse.” . Marijuana’s categorization under U.S. South Korea and Israel.
The War on Cannabis continues through aggressive state and local enforcement and prohibition measures with no end in sight. The issue of enforcement or compliance is probably the biggest one most states face at the policy level. Today, we’ll look at the argument that a compliance focus is better than an enforcement focus.
Last week, I wrote a piece entitled “ Deschedule Cannabis, Don’t Reschedule It.” ” The post came on the heels of President Joe Biden’s announcement that the federal government is considering the federal scheduling of cannabis.
They write… In this week’s edition: Plans to vote on cannabis banking legislation announced in both chambers of Congress, with predictions that House will pass the SAFE Act by the end of October. DEA increases the cannabis research quota. Battle heating up over Florida ballot initiative to legalize cannabis for adult use.
CPA’s” PUBLISHER: CANNABIS LAW REPORT. Numerous attempts to introduce legislation to relax the provisions that placed cannabis on Schedule I of the Controlled Substances Act [“CSA”] have been made beginning in 1981 [i]. It was not a policy priority of the Obama administration. In the 115th session of Congress, S.
Attorney General, and it is unclear whether this nominee will be better or worse than the former Attorney General Jeff Sessions when it comes to the growing cannabis momentum toward federal legality. She also supported abolishing the Obama administration’s more lenient policies for lower-level drug offenders, according to CBS News.
Cannabis and business immigration don’t mix. That’s not because a particular investment may not be sound, rather because federal law creates inherent conflicts between immigration eligibility and participating in a cannabis venture. Cannabis and immigration U.S. The INA is federal law and administered by the U.S.
According to a report from Marijuana Moment, President Trump has proposed ending an existing policy that protects state medical marijuana programs from Justice Department interference. Trump’s last two budgets omitted the medical cannabis protections language, and President Obama similarly asked for the policy to be removed.
President Trump proposed ending an existing policy that protects state medical marijuana programs from Justice Department interference as part of his fiscal year 2021 budget plan released on Monday. Trump’s last two budgets omitted the medical cannabis protections language, and President Obama similarly asked for the policy to be removed.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content